NAS:SAGE (USA) Also Trade In: Germany

Sage Therapeutics Inc $ 35.72 -1.66 (-4.44%)

Volume:
1,141,032
Avg Vol (1m):
1,253,568
Market Cap $:
1.85 Bil
Enterprise Value $:
1.02 Bil
P/E (TTM):
0.00
P/B:
2.18
Warning! GuruFocus has detected 1 Severe warning sign with SAGE. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 1Y (-%)

Financial Strength

6/10
Current Vs Industry Vs History
Cash-To-Debt 24.78
Equity-to-Asset 0.9
Debt-to-Equity 0.04
Debt-to-EBITDA -0.05
N/A
N/A
Piotroski F-Score 2
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 7.81
DISTRESS
GREY
SAFE
Beneish M-Score -6.08
Not Manipulator
Manipulator
WACC vs ROIC
ROIC -919.77 %
WACC 14.78 %

Profitability Rank

Current Vs Industry Vs History
Operating Margin % -7709.7
Net Margin % -7406.74
ROE % -59.62
ROA % -53.89
ROC (Joel Greenblatt) % -1531.71
3-Year EBITDA Growth Rate -42.7
3-Year EPS without NRI Growth Rate -41.2

Valuation Rank

Current Vs Industry Vs History
PB Ratio 2.18
PS Ratio 212.62
EV-to-EBIT -1.52
N/A
EV-to-EBITDA -1.52
N/A
EV-to-Revenue 117.04
Current Ratio 12.77
Quick Ratio 12.77
Days Payable 5065.18

Dividend & Buy Back

Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -10.9

Valuation & Return

Current Vs Industry Vs History
Price-to-Tangible-Book 2.18
Earnings Yield (Greenblatt) % -65.79